The FAS/cd95 promoter single-nucleotide polymorphism -670 A/G and lupus erythematosus

Clinical and Experimental Dermatology

Volumn 37, Issue 4, 2012, Pages 425-427

  Molin, S ^a,b   Weiss, E H ^b   Ruzicka, T ^a   Messer, G ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FAS ANTIGEN;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GERMANY; HUMAN; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84861201642     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04296.x     Document Type: Article

References (10)

1. Herrmann M, Voll RE, Zoller OM, et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1241-50. (Pubitemid 28313427)
2. Brink MR, Burakoff SJ,. Cytolytic pathways in haematopoietic stem-cell transplantation. Nat Rev Immunol 2002; 2: 273-81. (Pubitemid 37323227)
3. Farre L, Bittencourt AL, Silva-Santos G, et al. Fas -670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia. J Leukoc Biol 2008; 83: 220-2.
4. Agarwal K, Czaja AJ, Donaldson PT,. A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis. Tissue Antigens 2007; 69: 227-35. (Pubitemid 46696944)
5. Broen J, Gourh P, Rueda B, et al. The FAS -670A > G polymorphism influences susceptibility to systemic sclerosis phenotypes. Arthritis Rheum 2009; 60: 3815-20.
6. Kanemitsu S, Ihara K, Saifddin A, et al. A functional polymorphism in fas (CD95/APO-1) gene promoter associated with lupus erythematosus. J Rheumatol 2002; 29: 1183-8. (Pubitemid 34601951)
7. Huang QR, Danis V, Lassere M, et al. Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients. Rheumatology 1999; 38: 645-51. (Pubitemid 29507334)
8. Lee YH, Kim YR, Ji JD, et al. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus. J Rheumatol 2001; 28: 2008-11. (Pubitemid 32803777)
9. Nolsoe RL, Kelly JA, Pociot F, et al. Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia. Genes Immun 2005; 6: 699-706. (Pubitemid 41741715)
10. Araste JM, Sarvestani EK, Aflaki E, Amirghofran Z,. Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules. Immunol Invest 2010; 39: 27-38.